Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)

243
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
02/26/2015 02/27/2015 03/02/2015 03/03/2015 03/04/2015 Date
259(c) 258.8(c) 261(c) 260(c) 260.2 Last
1 831 750 1 769 532 1 718 635 2 445 415 2 688 561 Volume
+0.43% -0.08% +0.85% -0.38% +0.08% Change
More quotes
Company
Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics.As a large biotech company, Roche has truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.It is also a leader in in-vitro... 
Sector
Pharmaceuticals
Calendar
03/04 | 09:20amPresentation
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Financials ( CHF)
Sales 2015 46 432 M
EBIT 2015 16 496 M
Net income 2015 11 304 M
Debt 2015 7 673 M
Yield 2015 3,17%
Sales 2016 48 481 M
EBIT 2016 17 663 M
Net income 2016 12 343 M
Debt 2016 3 788 M
Yield 2016 3,39%
PER 2015 19,91
PER 2016 18,33
EV / Sales 2015 5,00x
EV / Sales 2016 4,71x
Capitalization 224 546 M
More Financials
Latest news on ROCHE HOLDING LTD.
03/03 ROCHE : Global scientific collaborators to explore latest pathology and oncology..
02/25 Biosimilar copies of blockbuster drug launch in major EU markets
02/19DJROCHE : Gets FDA Priority Review for Cancer Treatment
02/13 Swiss private bank Notenstein to buy rival La Roche
02/09DJEUROPE MARKETS : Greek Jitters, Chinese Data Knock European Stocks Sharply Lower
02/09DJEUROPE MARKETS : Greek Jitters, Chinese Data Knock European Stocks Sharply Lower
02/06 ROCHE : FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Tre..
02/05 Pfizer to buy Hospira for $15 billion to bolster hospital products
More news
Sector news Pharmaceuticals - NEC
11:40a NOVO NORDISK A/S : From Denmark to Mozambique: Health on Two Wheels
11:40aDJU.S. Government Bonds Little Changed on Mixed Data
11:38a RANBAXY LABORATORIES : & APICON BREAK GUINNESS WORLD RECORD™
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF